Close

Algernon Pharmaceuticals Announces Topline Data From its Phase 2b/3 COVID-19 Trial of Ifenprodil

Go back to Algernon Pharmaceuticals Announces Topline Data From its Phase 2b/3 COVID-19 Trial of Ifenprodil
Allergan Inc (NYSE: AGN) Delayed: 193.02 --0 (-0%)
Previous Close $193.02    52 Week High $322.68 
Open $15.33    52 Week Low $186.34 
Day High $193.02    P/E 45.96 
Day Low $193.02    EPS $4.20 
Volume 43,377       

(AMEX: AGNPF) Delayed: 0.08 --0 (-0%)
Previous Close $0.08    52 Week High
Open $0.08    52 Week Low
Day High $0.08    P/E N/A 
Day Low $0.08    EPS
Volume 140       

Merrill Accelerated Return Notes Linked to the S&P 500 Index (NYSE: AGW) Delayed: 5.50 --0 (-0%)
Previous Close $5.50    52 Week High $8.98 
Open $5.50    52 Week Low $2.98 
Day High $5.50    P/E N/A 
Day Low $5.50    EPS $0.00 
Volume 10,800       

(NYSE: PSYK) Delayed: 16.48 --0 (-0%)
Previous Close $16.48    52 Week High
Open $16.48    52 Week Low
Day High $16.48    P/E N/A 
Day Low $16.48    EPS
Volume 474,530